Barclays’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-11,279
Closed -$56K 4014
2021
Q3
$56K Buy
11,279
+5,546
+97% +$27.5K ﹤0.01% 3369
2021
Q2
$30K Buy
5,733
+4,595
+404% +$24K ﹤0.01% 3609
2021
Q1
$5K Buy
+1,138
New +$5K ﹤0.01% 3763
2020
Q3
Sell
-6,135
Closed -$16K 4030
2020
Q2
$16K Sell
6,135
-1,509
-20% -$3.94K ﹤0.01% 3592
2020
Q1
$22K Sell
7,644
-15,795
-67% -$45.5K ﹤0.01% 3366
2019
Q4
$90K Buy
23,439
+10,494
+81% +$40.3K ﹤0.01% 3470
2019
Q3
$66K Sell
12,945
-2,726
-17% -$13.9K ﹤0.01% 3592
2019
Q2
$97K Sell
15,671
-35,175
-69% -$218K ﹤0.01% 3605
2019
Q1
$362K Buy
50,846
+33,459
+192% +$238K ﹤0.01% 2763
2018
Q4
$148K Buy
17,387
+8,118
+88% +$69.1K ﹤0.01% 2830
2018
Q3
$186K Sell
9,269
-77,146
-89% -$1.55M ﹤0.01% 3112
2018
Q2
$2.23M Buy
86,415
+74,723
+639% +$1.93M ﹤0.01% 1382
2018
Q1
$279K Buy
11,692
+9,319
+393% +$222K ﹤0.01% 2648
2017
Q4
$80K Sell
2,373
-1,888
-44% -$63.6K ﹤0.01% 3115
2017
Q3
$90K Buy
4,261
+131
+3% +$2.77K ﹤0.01% 2732
2017
Q2
$72K Buy
4,130
+3,893
+1,643% +$67.9K ﹤0.01% 2891
2017
Q1
$4K Sell
237
-3,721
-94% -$62.8K ﹤0.01% 3688
2016
Q4
$66K Buy
3,958
+3,750
+1,803% +$62.5K ﹤0.01% 2736
2016
Q3
$3K Sell
208
-60
-22% -$865 ﹤0.01% 3552
2016
Q2
$4K Buy
268
+34
+15% +$507 ﹤0.01% 3181
2016
Q1
$3K Sell
234
-55
-19% -$705 ﹤0.01% 3179
2015
Q4
$8K Buy
289
+234
+425% +$6.48K ﹤0.01% 2852
2015
Q3
$1K Sell
55
-144
-72% -$2.62K ﹤0.01% 3813
2015
Q2
$5K Buy
199
+112
+129% +$2.81K ﹤0.01% 3633
2015
Q1
$1K Sell
87
-150
-63% -$1.72K ﹤0.01% 4014
2014
Q4
$4K Buy
237
+207
+690% +$3.49K ﹤0.01% 3964
2014
Q3
$1K Sell
30
-34
-53% -$1.13K ﹤0.01% 4255
2014
Q2
$1K Buy
+64
New +$1K ﹤0.01% 4245